Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode

Shevalev, O., Bischof, L., Sapegin, A., Bunev, A., Grigoreva, O., Kantin, G., et al. (2024). Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode. European Journal of Medicinal Chemistry, 270: 116328. doi:10.1016/j.ejmech.2024.116328.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Shevalev, O, Autor
Bischof, L1, 2, Autor                 
Sapegin, A, Autor
Bunev, A, Autor
Grigoreva, O, Autor
Kantin , G, Autor
Kalinin, S, Autor
Hartmann, MD1, 2, Autor                 
Affiliations:
1Molecular Recognition and Catalysis Group, Department Protein Evolution, Max Planck Institute for Biology Tübingen, Max Planck Society, ou_3477391              
2Department Protein Evolution, Max Planck Institute for Biology Tübingen, Max Planck Society, Max-Planck-Ring 5, 72076 Tübingen, DE, ou_3371683              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: The vast majority of current cereblon (CRBN) ligands is based on the thalidomide scaffold, relying on glutarimide as the core binding moiety. With this architecture, most of these ligands inherit the overall binding mode, interactions with neo-substrates, and thereby potentially also the cytotoxic and teratogenic properties of the parent thalidomide. In this work, by incorporating a spiro-linker to the glutarimide moiety, we have generated a new chemotype that exhibits an unprecedented binding mode for glutarimide-based CRBN ligands. In total, 16 spirocyclic glutarimide derivatives incorporating an isoxazole moiety were synthesized and tested for different criteria. In particular, all ligands showed a favorable lipophilicity, and several were able to outperform the binding affinity of thalidomide as a reference. In addition, all compounds showed favorable cytotoxicity profiles in myeloma cell lines and human peripheral blood mononuclear cells. The novel binding mode, which we determined in co-crystal structures, provides explanations for these improved properties: The incorporation of the spiro-isoxazole changes both the conformation of the glutarimide moiety within the canonical tri-trp pocket and the orientation of the protruding moiety. In this new orientation it forms additional hydrophobic interactions and is not available for direct interactions with the canonical neo-substrates. We therefore propose this chemotype as an attractive building block for the design of PROTACs.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2024-032024-04
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: DOI: 10.1016/j.ejmech.2024.116328
PMID: 38552426
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: European Journal of Medicinal Chemistry
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: Elsevier
Seiten: 10 Band / Heft: 270 Artikelnummer: 116328 Start- / Endseite: - Identifikator: ISSN: 0223-5234
CoNE: https://pure.mpg.de/cone/journals/resource/0223-5234